The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 829 | 20,000 | SH | SOLE | 829 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 10,586 | 434,400 | SH | SOLE | 10,586 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,321 | 192,500 | SH | SOLE | 1,321 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 6,525 | 578,500 | SH | SOLE | 6,525 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 626 | 25,000 | SH | SOLE | 626 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,555 | 167,054 | SH | SOLE | 9,555 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 10,665 | 139,000 | SH | SOLE | 10,665 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 13,460 | 393,000 | SH | SOLE | 13,460 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 4,711 | 705,218 | SH | SOLE | 4,711 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,283 | 246,200 | SH | SOLE | 6,283 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 489 | 6,000 | SH | SOLE | 489 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 9,385 | 842,500 | SH | SOLE | 9,385 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 4,286 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
C4 THERAPEUTICS INC | COM STK | 12529R107 | 3,644 | 110,000 | SH | SOLE | 3,644 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 8,566 | 1,357,500 | SH | SOLE | 8,566 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 28,514 | 1,627,500 | SH | SOLE | 28,514 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 3,425 | 1,250,000 | SH | SOLE | 3,425 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 15,197 | 319,000 | SH | SOLE | 15,197 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 6,794 | 537,500 | SH | SOLE | 6,794 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 4,341 | 530,000 | SH | SOLE | 4,341 | 0 | 0 | ||
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,172 | 150,000 | SH | SOLE | 1,172 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,894 | 330,000 | SH | SOLE | 1,894 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 7,992 | 682,500 | SH | SOLE | 7,992 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 5,028 | 392,500 | SH | SOLE | 5,028 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 13,095 | 283,500 | SH | SOLE | 13,095 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 7,647 | 164,800 | SH | SOLE | 7,647 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 8,378 | 1,212,500 | SH | SOLE | 8,378 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 5,794 | 562,500 | SH | SOLE | 5,794 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 508 | 5,000 | SH | SOLE | 508 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 20,821 | 637,500 | SH | SOLE | 20,821 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 18,479 | 863,100 | SH | SOLE | 18,479 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 3,613 | 32,500 | SH | SOLE | 3,613 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 18,467 | 694,000 | SH | SOLE | 18,467 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 279 | 2,500 | SH | SOLE | 279 | 0 | 0 | ||
ONCORUS INC | COM | 68236R103 | 1,730 | 53,500 | SH | SOLE | 1,730 | 0 | 0 | ||
PANACEA ACQUISITION CORP | *W EXP 07/07/202 | 698102118 | 299 | 93,332 | SH | SOLE | 299 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 923 | 15,000 | SH | SOLE | 923 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 4,162 | 75,645 | SH | SOLE | 4,162 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 4,140 | 209,600 | SH | SOLE | 4,140 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 3,848 | 120,000 | SH | SOLE | 3,848 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 7,916 | 207,500 | SH | SOLE | 7,916 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 1,097 | 20,000 | SH | SOLE | 1,097 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 22,129 | 255,800 | SH | SOLE | 22,129 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 5,729 | 92,500 | SH | SOLE | 5,729 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 9,235 | 999,500 | SH | SOLE | 9,235 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 10,353 | 465,500 | SH | SOLE | 10,353 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 11,812 | 803,000 | SH | SOLE | 11,812 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 5,112 | 2,400,000 | SH | SOLE | 5,112 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 14,550 | 7,500,000 | SH | SOLE | 14,550 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 846 | 107,500 | SH | SOLE | 846 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,230 | 80,000 | SH | SOLE | 1,230 | 0 | 0 |